Lakefront Biotherapeutics NV (LKFT) — Net Asset Momentum
Lakefront Biotherapeutics NV (LKFT) recorded a net asset momentum of 11.7% as of December 2025, with net assets of $3.24 Billion USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See LKFT net asset value for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Lakefront Biotherapeutics NV Net Asset Momentum (2022–2025)
This chart tracks Lakefront Biotherapeutics NV's year-over-year net asset growth across 4 annual reporting periods from 2022 to 2025. The most recent momentum reading is +11.7%, with net assets of $3.24 Billion USD as of December 2025. Check LKFT intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Net Asset History for Lakefront Biotherapeutics NV (2022–2025)
The table below shows the complete annual net asset history for Lakefront Biotherapeutics NV from 2022 to 2025, covering 4 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see LKFT stock market capitalisation.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $3.24 Billion | $3.41 Billion | $170.65 Million | ▲ +11.7% |
| 2024 | $2.90 Billion | $4.14 Billion | $1.24 Billion | ▲ +3.6% |
| 2023 | $2.80 Billion | $4.36 Billion | $1.56 Billion | ▲ +10.7% |
| 2022 | $2.53 Billion | $4.73 Billion | $2.21 Billion | — |